US Patent 10646575 Heterocyclic degronimers for target protein degradation
Patent 10646575 was granted and assigned to C4 Therapeutics on May, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 9, 2018
Date of Patent
May 12, 2020
Patent Applicant
Patent Application Number
16186339
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10646575 Heterocyclic degronimers for target protein degradation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
